The Silverstein Group
  • Home
  • Services
  • Rustin Silverstein
  • Contact Us

Mass Tort Ad Watch Blog



Contact us for customized reports

Risperdal remains top target of plaintiffs' lawyer ads 

5/27/2014

0 Comments

 
Picture
April marked the seventh month in a row that plaintiffs’ attorney advertisers spent over $3 million on ads seeking claims related to Risperdal, an antipsychotic drug by Janssen Pharmaceuticals, a unit of Johnson & Johnson.  


The drug has been among the top two drugs or medical devices targeted in mass tort ads since October 2013.

Nearly 6,000 Risperdal mass tort ads ran in April. Over 85% of ad spending was devoted to ads aired on national cable and broadcast networks.  The law firms of Pulaski & Middleman and Meyer Blair spent more on Risperdal ads than all other law firms combined.

In early November, Johnson & Johnson agreed to pay more than $2.2 billion in criminal and civil fines to settle accusations that is improperly promoted Risperdal to older adults, children and people with disabilities.

According to court records, Janssen has reached settlements in some 80 Risperdal suits in Philadelphia. Trials in a new set of cases are expected to begin in July.


Picture
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    The Silverstein Group provides comprehensive analyses of advertising by attorneys and law firms in 211 media markets and on 11 national broadcast networks and more than 80 national cable networks.

    Archives

    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    December 2013
    October 2013
    September 2013

    Categories

    All

    RSS Feed

Powered by Create your own unique website with customizable templates.